Biotech · Private company · San Diego, CA, US
Third Element Bio Inc.
Track this companyFree. Adds Third Element Bio Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- Isoform-targeting therapeutic development for the human brainFiscal year 2026 · $404.7KNIH RePORTER 1R43AG099790-01A1 · fetched Nov 12, 2026
- Development of a RUNX1 modulator to slow cognitive decline in Alzheimer's diseaseFiscal year 2026 · $101.3KNIH RePORTER 5R43AG087766-02 · fetched Nov 12, 2026
- Development of a RUNX1 modulator to slow cognitive decline in Alzheimer's diseaseFiscal year 2025 · $391.9KNIH RePORTER 1R43AG087766-01A1 · fetched Nov 12, 2026